Documentos relacionados

1. Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients.
2. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
3. Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
4. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.
5. [The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation].
6. Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs.
7. Cytomegalovirus Genotype Distribution among Congenital and Perinatal Infected Patients with CMV-Associated Thrombocytopenia.
8. Association between cytomegalovirus seropositivity and all-cause mortality: An original cohort study.
9. Indirect effects of cytomegalovirus infection: Implications for vaccine development.
10. Association between mortality and cytomegalovirus reactivation during remission induction therapy in patients with rheumatic diseases.